🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Several experts stated the demand for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Material Elimination

Based on TikTok, the platform has removed violative content and prohibited related keywords and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.

Within minutes of entering one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Details and Costs

Inside these communities, posts show black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they cannot confirm. Although the research behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially serious health risks”.